Multimodality Therapy and Survival Outcomes in Resectable Primary Small Cell Carcinoma of the Esophagus: A Multicenter Retrospective Study

被引:1
作者
Lei Xu [1 ]
Yu-shang Yang [2 ]
Bin Li [3 ]
Yu-qin Cao [4 ]
Si-yun Lin [5 ]
Yong-kui Yu [6 ]
Hou-nai Xie [7 ]
Hao-miao Li [6 ]
Yong Yuan [2 ]
Xian-Kai Chen [1 ]
Yong Li [1 ]
Jian-jun Qin [1 ]
Lin Zhang [7 ]
Xian-ben Liu [6 ]
Li-jie Tan [5 ]
He-cheng Li [4 ]
Jia-qing Xiang [3 ]
Long-qi Chen [2 ]
Rui-xiang Zhang [1 ]
Yin Li [1 ]
机构
[1] National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Department of Thoracic Surgery
[2] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Thoracic Surgery
[3] West China Hospiatal,Departments of Thoracic Surgery
[4] Sichuan University,Department of Thoracic Surgery
[5] Fudan University Shanghai Cancer Center,Department of Thoracic Surgery
[6] Ruijin Hospital,Department of Thoracic Surgery
[7] Shanghai Jiao Tong University School of Medicine,Department of Thoracic Surgery
[8] Zhongshan Hospital Affiliated to Fudan University,undefined
[9] The Affiliated Cancer Hospital of Zhengzhou University,undefined
[10] Henan Cancer Hospital,undefined
[11] Shandong Provincial Hospital Affiliated to Shandong First Medical University,undefined
关键词
Primary small cell carcinoma of the esophagus; Surgery; Adjuvant therapy; Neoadjuvant therapy; Survival;
D O I
10.1245/s10434-024-16532-x
中图分类号
学科分类号
摘要
引用
收藏
页码:848 / 859
页数:11
相关论文
empty
未找到相关数据